Home Amines 556803-08-8
556803-08-8,MFCD04788042
Catalog No.:AA00DDAC

556803-08-8 | 2-([5-(Benzylamino)-1,3,4-thiadiazol-2-yl]sulfanyl)-n-(cyclohexylmethyl)acetamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98% by HPLC
in stock  
$224.00   $157.00
- +
10mg
98% by HPLC
in stock  
$335.00   $234.00
- +
25mg
98% by HPLC
in stock  
$637.00   $446.00
- +
50mg
98% by HPLC
in stock  
$1,040.00   $728.00
- +
100mg
98% by HPLC
in stock  
$1,752.00   $1,227.00
- +
250mg
98%
in stock  
$3,956.00   $2,769.00
- +
500mg
98% by HPLC
in stock  
$5,515.00   $3,861.00
- +
1000mg
98% by HPLC
in stock  
$8,787.00   $6,151.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00DDAC
Chemical Name:
2-([5-(Benzylamino)-1,3,4-thiadiazol-2-yl]sulfanyl)-n-(cyclohexylmethyl)acetamide
CAS Number:
556803-08-8
Molecular Formula:
C18H24N4OS2
Molecular Weight:
376.5394
MDL Number:
MFCD04788042
SMILES:
O=C(CSc1nnc(s1)NCc1ccccc1)NCC1CCCCC1
Properties
Computed Properties
 
Complexity:
401  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
8  
XLogP3:
4.7  

Literature

Title: TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.

Journal: Neuropharmacology 20120901

Title: Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.

Journal: British journal of pharmacology 20120601

Title: Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.

Journal: The Journal of pharmacology and experimental therapeutics 20101201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:556803-08-8 Molecular Formula|556803-08-8 MDL|556803-08-8 SMILES|556803-08-8 2-([5-(Benzylamino)-1,3,4-thiadiazol-2-yl]sulfanyl)-n-(cyclohexylmethyl)acetamide